Melanie Ambler, a student at the Stanford School of Medicine and "physician artist," playing the cello and learning to care for patients.
Researchers have found parallels between the degeneration of a neurons in a tiny sea invertebrate and the human brain.
Researchers at Stanford Medicine have discovered a possible molecule connection between Down syndrome and Alzheimer's disease.
Stanford researchers have linked the brain's blood vessel system to the development of Alzheimer's disease.
Researchers find that the ribosome, a protein-making machine, may contribute to diseases of aging, such as Alzheimer's and Parkinson's.
In a Stanford Medicine magazine Q&A, flutist Eugenia Zukerman discusses finding joy through music and poetry since her Alzheimer's diagnosis.
Stanford Medicine researchers are investigating new tactics to overcome cognitive loss, including that which occurs in Alzheimer's disease.
During cardiac surgery, patients’ blood levels of a substance highly predictive of Alzheimer’s disease jumped more than 5-fold.
There's a lot we can do to improve brain health and counteract genetic factors for memory loss, Stanford neuroscientist Sharon Sha says in a podcast.
A new study has identified T cells targeting the Epstein-Barr virus in autopsied Alzheimer's brains and in cerebrospinal fluid of Alzheimer's patients.
In this 1:2:1 podcast, host Paul Costello talks with Eugenia Zukerman, who is living with Alzheimer's disease and has a new book of poetry.
People with a mutation in an enzyme that breaks down alcohol may be at a higher risk for developing Alzheimer's disease, new research suggests.
Brain cells called microglia keep brains young by eliminating accumulations of protein debris. But their garbage-colllection ability fades with age.
Stanford engineer Ellen Kuhl is using computer modeling to provide insight into the progress of neurodegenerative diseases like Alzheimer's.
With half of all cases of Alzheimer's disease and related dementias going undiagnosed, researchers develop app to help in early screening
It's not every day that early-stage research at Stanford's School of Medicine generates its own New Yorker cartoon. But a few years ago, news of a …